Ron Owens

Ron Owens

Mr. Owens began his career in 1986 and has over 25 years of financial experience. He joined Evening Post Industries in 2012 as Vice President of Finance and became CFO in 2014. He is also responsible for business diversification and acquisition. Mr. Owens joined EPI Health's leadership team in April 2017. Prior to joining EP Industries, Mr. Owens served as the President of Kiawah Capital and as director for a high yield bond fund. Additionally, he serves on the Executive Committee of the Lowcountry Housing Trust.

Chuck Jenkins

Chuck Jenkins has more than 15 years of progressive experience in pharmaceutical sales, sales management, marketing and business development. He joined EPI's leadership team in April 2017 through the acquisition of Cipher Pharmaceuticals. Previously Mr. Jenkins was the co-founder of Innocutis Medical, LLC and held numerous commercial positions at both Ferndale Laboratories and Medicis Pharmaceuticals. Mr. Jenkins has commercialized dermatology products exceeding $750M in revenue.

Mr. Jenkins received his Bachelors of Science in Business Administration degree from The University of South Carolina.

Robert Dougherty

Rob brings over 20 years of sales, marketing, and management experience in a number of therapeutic areas, most notably Dermatology. Prior to joining EPI Health, he was a founding member and National Sales Director of Promius Pharma, the branded dermatology division of Dr. Reddy's Laboratories. Previously, he was a Regional Sales Manager for Dermik Laboratories, a division of Sanofi Aventis, and a District Manager, National Sales Trainer, and Key Account Manager for Bertek Pharmaceuticals, a division of Mylan Laboratories. Throughout his career, Rob and his teams have been recognized for multiple awards for sales excellence.